Keyphrases
Prostate Cancer
63%
Prostate Cancer Screening
42%
Kallikrein
42%
Radical Prostatectomy
38%
High-grade Prostate Cancer
35%
Robot-assisted Laparoscopic Radical Prostatectomy
34%
Prostate
29%
Androgen Deprivation Therapy
26%
Randomized Trial
24%
Magnetic Resonance Imaging
24%
Randomized Clinical Trial
23%
Prostate-specific Antigen
23%
Screening Decisions
21%
Atorvastatin
21%
Endopelvic Fascia
21%
Prostate Cancer Progression
21%
12-month Outcomes
21%
Postoperative Incontinence
21%
Personalized Medicine
21%
Laparoscopic Radical Prostatectomy
21%
Sexual Behavior
21%
Metastasis
21%
Clinical Suspicion
21%
Molecular Research
21%
Molecular Diagnostics
21%
Multi-sampling
21%
Origin Tracing
21%
Fresh-frozen
21%
Three-dimensional (3D)
21%
Cancer Origin
21%
Multiparametric MRI (mpMRI)
21%
Shared Decision Making
21%
Decision Aid
21%
PAXgene
21%
Surgical Pathology
21%
Paraffin-embedded Tissue
21%
Genome Analysis
21%
After Surgery
21%
Formalin-fixed Paraffin-embedded Tissue
21%
Retrospective multicenter Study
21%
Catheter
21%
Cumulative Incidence
21%
Randomized Double-blind
21%
Core Length
21%
Prostate Biopsy
21%
Vesicourethral Anastomosis
21%
Randomized Controlled Trial
21%
Robot-assisted
21%
Paraffin Blocks
21%
Multiple Cores
21%
Medicine and Dentistry
Prostate Cancer
100%
Prostatectomy
55%
Incontinence
29%
Cancer Screening
28%
Cancer Growth
24%
Magnetic Resonance Imaging
24%
Clinical Study
24%
Randomized Clinical Trial
22%
Biopsy Technique
22%
Malignant Neoplasm
21%
Diagnosis
21%
Androgen Deprivation Therapy
21%
Formaldehyde
21%
Fascia
21%
Personalized Medicine
21%
Randomized Controlled Trial
21%
Overdiagnosis
21%
Observational Study
21%
Atorvastatin
21%
Kallikrein
21%
Genome Analysis
21%
Shared Decision Making
21%
Molecular Research
21%
Screening of Prostate Cancer
21%
Prostate Biopsy
21%
Prostate Specific Antigen
21%
Evolution
21%
Robot-Assisted Prostatectomy
18%
Metastatic Carcinoma
17%
Statin
15%
Urine Incontinence
13%
Urinary System
13%
Enuresis
13%
Placebo
12%
Continence
11%
Cumulative Incidence
9%
Surgical Technique
9%
Surgical Margin
8%
Biochemical Recurrence
8%
Primary Tumor
7%
Needle Biopsy
7%
Arm
6%
Immunohistochemistry
6%
Recurrent Disease
6%
Diagnostic Pathology
6%
DNA Sequence
6%
Cancer Grading
5%